AACE Symposium on the Endocrine Aspects of Obesity

Atlanta, GA

Vertical Tabs

Overview

Obesity is a disease, requiring a concerted therapeutic focus according to the "medical" model.  The advent of new medications fill the previous void in the lack of effective options for medical therapy.  The patient treatment goal is to achieve the degree of weight loss sufficient to achieve targets for improving complications and reducing risk.  Employing risk stratification methods and appropriate patient selection for various treatment options and intensity of treatment options can optimize risk/benefit ratio and patient outcomes.  This educational activity will present these integral themes and address all relevant aspects of obesity epidemiology, pathophysiology, complications, and treatment.

Target Audience

This activity is intended for MD's, DO's, NP's, RN's, PA's, CDE's, Pharmacists and other interested health care providers.

 

LEARNER BILL OF RIGHTS

The American Association of Clinical Endocrinologists (AACE) recognizes that you are a life-long learner who has chosen to engage in continuing medical education to identify or fill a gap in knowledge, skill or performance.  As part of AACE’s duty to you as a learner, you have the right to expect that your continuing medical education experience with AACE includes:

 

CONTENT that:

  • Promotes improvements or quality in healthcare;
  • Is valid, reliable and accurate;
  • Offers balanced presentations that are free of commercial bias for or against a product/service;
  • Is vetted through a process that resolves any conflicts of interests of planners, teachers or authors;
  • Is driven and based on learning needs, not commercial interests;
  • Addresses the stated objectives or purpose; and
  • Is evaluated for its effectiveness in meeting the identified educational need.

 

A LEARNING ENVIRONMENT that:

  • Supports learners’ ability to meet their individual needs;
  • Respects and attends to any special needs of the learners;
  • Respects the diversity of groups of learners; and
  • Is free of promotional, commercial and/or sales activities.

 

DISCLOSURE of:

  • Relevant financial relationships planners, teachers and authors have with commercial interests related to the content of the activity; and
  • Commercial support (funding or in-kind resources) of the activity.
Agenda

Tuesday, November 12, 2013

1:30 pm - 5:30 pm EST

AACE Symposium on the Endocrine Aspects of Obesity

  

Time   Agenda Item
1:30pm - 1:35pm             Welcome and Introduction - Jeffrey I. Mechanick, MD
1:35pm - 1:55pm   Complication-Centric Risk Stratification Paradigm - W. Timothy Garvey, MD
1:55pm - 2:15pm   The Moleculary Basis of Obesity - Jeffrey I. Mechanick, MD
2:15pm - 2:35pm   Comprehensive Management Strategy for Obesity - Alan J. Garber, MD
2:35pm - 3:00pm   Cardiovascular Disease Risk with Obesity - Daniel L. Hurley, MD
3:00pm - 3:15pm   Panel Discussion - Jeffrey I. Mechanick, MD (Moderator)
3:15pm - 3:30pm   Break
3:30pm - 4:00pm   Obesity as a Pre-Diabetes Condition - W. Timothy Garvey, MD
4:00pm - 4:30pm   Comprehensive Management Strategy for Type-2 Diabetes - Alan J. Garber, MD
4:30pm - 5:00pm   Endocrine Disruption in Obesity - Daniel L. Hurley, MD
5:00pm - 5:10pm   The AACE Obesity Algorithm - W. Timothy Garvey, MD
5:10pm - 5:30pm   Panel Discussion - Jeffrey I. Mechanick, MD (Moderator
 5:30pm   Wrap-Up and Adjournment - Jeffrey I. Mechanick, MD

 *Agenda Subject to Change

 

The activity is co-provided/co-sponsored by the American Association of Clinical Endocrinologists and the Postgraduate Institute for Medicine.

 

                

Faculty

*W. Timothy Garvey, MD - Chair

Professor and Chair, Department of Nutrition Sciences

University of Alabama at Birmingham (UAB)

Director, UAB Diabetes Research Training Center, Birmingham, AL

 

*Alan J. Garber, MD, PhD, FACE

Professor, Departments of Medicine, Biochemistry and Molecular Biology, and Molecular and Cellular Biology

Baylor College of Medicine, Houston, TX

 

Daniel L Hurley, MD, FACE

Assistant Professor of Medicine

Mayo Clinic

Rochester, MN

 

*Jeffrey I. Mechanick, MD, FACP, FACE, FACN, ECNU

Clinical Professor of Medicine

Director, Metabolic Support

Division of Endocrinology, Diabetes & Bone Disease

Icahn School of Medicine at Mount Sinai

New York, NY

 

  

 

*Denotes individual is both a member of the Steering Committee and Faculty.

 

Educational Objectives

At the conclusion of this educational activity, the participant should be able to:

  • Utilize an obesity complication-based risk stratification paradigm for management.
  • Describe a comprehensive approach to obesity management.
  • Explain the molecular and endocrine signaling aspects of obesity.
Steering/Program Committee

*Alan J. Garber, MD, PhD, FACE - Chair

Professor, Departments of Medicine, Biochemistry and Molecular Biology, and Molecular and Cellular Biology

Baylor College of Medicine, Houston, TX

 

*W. Timothy Garvey, MD

Professor and Chair, Department of Nutrition Sciences

University of Alabama at Birmingham (UAB)

Director, UAB Diabetes Research Training Center, Birmingham, AL

 

George Grunberger, MD, FACP, FACE

Chairman, Grunberger Diabetes Institute

Clinical Professor, Department of Internal Medicine Center for Molecular Medicine & Genetics

Wayne State University School of Medicine, Bloomfield Hills, MI

 

Janet B. McGill, MD, FACE

Professor of Medicine, Washington University School of Medicine, St. Louis, MO

 

*Jeffrey I. Mechanick, MD, FACP, FACE, FACN, ECNU

Clinical Professor of Medicine

Director, Metabolic Support

Division of Endocrinology, Diabetes & Bone Disease

Icahn School of Medicine at Mount Sinai

New York, NY

 

 

 

 

*Denotes individual is both a member of the Steering Committee and Faculty.

 

Disclosure

Faculty Disclosures

*Dr. Alan Garber reports that he has received Advisory Board, consultant,and Speaker’s Bureau’s fees from Merck & Co., Inc., Novo Nordisk A/S, and VIVUS Inc.; Advisory Board fees from Halozyme Therapeutics; Advisory Board and Speaker’s Bureau fees from Janssen Pharmaceuticals, Inc.; Advisory Board and consultant fees from Takeda Pharmaceuticals North America, Inc.; consultant and Speaker’s Bureau fees from Santarus Inc.; consultant fees from Tethys Bioscience and Viking Therapeutics; and Speaker’s Bureau fees from Eisai Co, Ltd. He also reports that his presentation will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Garber has an identified conflict of interest and it has been resolved accordingly.  He has been required by the AACE CME Accreditation Committee to base his presentation and recommendations on the best available, preferably published evidence/information.

 

*Dr. Timothy Garvey reports that he has received research support and speaker honoraria from Merck & Co., Inc.; research support from Amylin Pharmaceuticals, Inc., and Weight Watchers International, Inc.; and Advisory Board honoraria from Alkermes, Daiichi-Sanko Company, Limited, Janssen Pharmaceuticals, Inc., LipoScience Inc., Tethys Bioscience, and VIVUS. He also reports that his presentation will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Garvey has an identified conflict of interest, and it has been resolved accordingly.  He has been advised by the AACE CME Accreditation Committee to base his presentation and recommendations on the best available, preferably published evidence/information.

 

Dr. Daniel Hurley reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his presentation will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Hurley has no identified conflicts of interest.

 

*Dr. Jeffrey Mechanick reports that he has received lecture/program development honoraria from Abbott Laboratories. He also reports that his presentation will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Mechanick has an identified conflict of interest and it has been resolved accordingly.  He has been required by the AACE CME Accreditation Committee to base his presentation and recommendations on the best available, preferably published evidence/information.

  

Steering Committee Disclosures

Dr. George Grunberger reports that he has received speaker honoraria and research support for his role as Investigator from Amylin Pharmaceuticals, Inc., Eli Lilly and Company, Novo Nordisk A/S, and Valeritas, Inc., speaker honoraria from Amarin Corp. and Santarus Inc., and research support for his role as Investigator from GlaxoSmithKline plc and Janssen Pharmaceuticals, Inc.  Dr. Garvey has no identified conflicts of interest.  

 

Dr. Janet McGill reports that she has received grant support for her role as Washington University Principal Investigator from Andromeda Biotech Ltd., Bristol-Myers Squibb/AstraZeneca, Mannkind Corporation, Novartis AG, Takeda Pharmaceuticals North America, Inc. and sanofi-aventis U.S. LLC; speaker/advisor honoraria from Boehringer Ingelheim GmbHI/Eli Lilly and Company and Merck & Company, Inc.; advisor honoraria from Abbott Laboratories, Halozyme Therapeutics, Janssen Pharmaceuticals Inc., and Novo Nordisk  A/S; and consultant honoraria from Reata Pharmaceuticals Inc. and Vitae Pharmaceuticals.  Dr. McGill has no identified conflicts of interest.

    

*Denotes individual is also a member of the Steering Committee.

 

Postgraduate Institute for Medicine Disclosures

The following PIM planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, and Jan Schultz, RN, MSN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Corporate Support

 This is activity is supported by an educational grant from VIVUS, Inc.

Physician Credit

This activity has been approved for AMA PRA Category 1 Credit(s)™. 

Nursing Credit

Credit Designation

This educational activity for 3.7 contact hours is provided by Postgraduate Institute for Medicine.

 

Accreditation Statement

Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Postgraduate Institute for Medicine is approved by the California Board of Registered Nursing, Provider Number 13485 for 3.7 contact hours.

There is no fee for this educational activity. A statement of credit will be issued only upon receipt of a completed online evaluation and a certificate will be made available immediately.

For information about ACPE and ANCC accreditation, please contact Postgraduate Institute for Medicine at (303) 799-1930 or information@pimed.com.

Pharmacist Credit

 

Accreditation Statement

Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

Credit Designation

Postgraduate Institute for Medicine designates this continuing education activity for 4.0 contact hour(s) (0.40 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0809-9999-13-308-L01-P)

Type of Activity: Application

Upon receipt of a completed online activity evaluation form, transcript information will be available at www.mycmemonitor.net immediately.

For information about ACPE and ANCC accreditation, please contact Postgraduate Institute for Medicine at (303) 799-1930 or information@pimed.com.

Dietitian Credit

Dietician Credit

This activity has been approved by the Commission on Dietetic Registration for 3.75 CPEUs

Location

Georgia World Congress Center

285 Andrew Young International Blvd., NW Atlanta, Georgia 30313-1591

contactus@gwcc.com

Phone: (404) 223-4000

 

Housing

Atlanta Marriott Marquis

265 Peachtree Center Ave NE  

Atlanta, GA 30303

 

Omni Hotel at CNN Center

190 Marietta St NW

Atlanta, GA 30303

 

Hyatt Regency Atlanta

265 Peachtree St NE

Atlanta, GA 30303

 

All housing reservations must be made through the attendee registration page: http://obesityweek.com/attendee/registration/ 

Registration Fees

AACE Membership is not required to attend this program.

 

Click the following link to view registration rates: http://media.obesityweek.com/PDF/OW2013-PricingGuide-20130809.pdf
Register

To Register, please click the following link:

 

http://registration3.experientevent.com/showOBW131/

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.